FDA clears Pfiz­er and Mod­er­na's bi­va­lent boost­ers, seek­ing to slow the next wave of Omi­cron

As part of an at­tempt to halt a like­ly new surge of hos­pi­tal­iza­tions and deaths from Omi­cron’s BA.5 sub­vari­ant this fall, the FDA on Wednes­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.